关于撤稿风波

发布时间：2018-04-24 01:36

本文选题：撤稿 + 审稿人　；参考：《实用心脑肺血管病杂志》2017年04期

【摘要】：正2017年4月20日,学术出版商Springer Nature发表声明,撤下其旗下杂志Tumor Biol已发表的107篇研究,而这些研究均来自中国。此次的撤稿原因为这些论文涉嫌伪造同行评审,作者推荐审稿人时使用了审稿人的真实姓名,通过假冒审稿人的真实邮件提供积极、赞许的审稿意见而使文章得以发表。此事闹得沸沸扬扬,甚嚣尘上。看今人不肖,思先贤教诲。清·叶天士《临证指南医案·华序》有言,"良医处世,不矜名,不计利,此其立德也;挽回造化,立起沉疴,此其立功也;阐发蕴奥,聿著方书,此其立言也。一艺而三善
[Abstract]:On April 20, 2017, academic publisher Springer Nature issued a statement withdrawing 107 studies published in its Tumor Biol magazine, all from China. The reason for this withdrawal is that these papers are suspected of falsifying peer reviews. The authors recommended the reviewers by using the real name of the reviewers, providing positive and approvingly approved opinions for publication by impersonating the true emails of the reviewers. There was a great deal of uproar about the matter. Look at people today, think of the teachings of the sages. In the Qing Dynasty, Ye Tianshi's "Clinical Guide to Medical cases" has a saying, "good doctors treat the world with no pride in fame, no consideration for profit, this is also the establishment of virtue; to save the creation, to set up a serious disease, this is also the meritorious; to elucidate the arcane, Lut Fang Shu, this also stand up the words." One skill and three good
【分类号】：+

【相似文献】